MEDIATION OF ANTIBODY-INDUCED GLOMERULAR INJURY
MEDIATION OF ANTIBODY-INDUCED GLOMERULAR INJURY
批准号:
3229741
负责人:
DAVID J SALANT
金额:
$28.68万
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-07-01 至 1996-03-31
关键词:
antigen antibody reaction basement membrane collagen complement cytoskeleton cytotoxicity disease /disorder model enzyme linked immunosorbent assay epithelium extracellular matrix proteins freeze etching glomerulonephritis high performance liquid chromatography human tissue immune complex diseases immunoelectron microscopy in situ hybridization inositol phosphates kidney circulation laboratory rat laminin marine animal oil membrane lipids membrane reconstitution /synthesis messenger RNA nutrition related tag phospholipids proteinuria radiotracer renal glomerulus tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term goals of this program are to define the humoral mechanisms
of glomerular damage. Attention is presently focused on the visceral
glomerular epithelial cell (GEC) as the target of antibody-directed,
complement-mediated injury. The proposal utilizes passive Heymann
nephritis (PHN) in rats, a model that faithfully reproduces many features
of human membranous nephropathy.
Specific aim 1 is based on two observations. Fish oil feeding
ameliorates glomerular injury in PHN, and complement causes membrane
phospholipid hydrolysis and intracellular calcium mobilization in
cultured GECs . Three groups of experiments are proposed to examine the
beneficial effects of fish oil. Cell membrane phospholipids of rat GECs
in culture will be enriched with either omega-3 (n-3) or omega-6 (n-6)
fatty acids and the response to complement attack will be compared in
terms of: their susceptibility to sublethal cytotoxicity; alterations in
phospholipid hydrolysis and intracellular calcium levels; and changes in
cell membrane fluidity. The functional effects of n-3 fatty acid
substitution of target GECs, independent of systemic influences, will be
examined in the isolated perfused rat kidney. Glomerular hemodynamic
effects will be studied in vivo by micropuncture and macromolecular
sieving techniques.
Specific aim 2 is designed to determine if the GEC cytoskeleton plays a
role in the morphological and functional changes that accompany
complement-mediated injury in PHN. Morphological, labelling and
functional techniques, and agents that either disrupt or stabilize
microfilaments and microtubules will be used to study the effect of
complement on the GEC cytoskeleton in cell culture and in the isolated
kidney.
Specific aim 3 examines the role of antibody and complement on
extracellular matrix production in PHN. The work will extend preliminary
findings in which cells occupying the periphery of PHN glomeruli
selectively expressed mRNA transcripts that hybridize in situ to a probe
for the a1 chain of type I collagen. Two groups of studies are planned.
First, studies will be done in vivo to define the time course of type I
collagen mRNA expression and relate it to the expression of type IV
collagen and laminin by in situ hybridization. RNA from PHN and control
glomeruli will be analyzed by Northern blot and ribonuclease protection
assays and compared to RNA from rat fibroblasts to determine if
hybridization is to genuine type I collagen mRNA. Immunodetection
techniques will be used to determine if type I collagen is intercalated
into the basement membrane or secreted into the urinary space. Second,
rat GECs in culture will be used to develop an in vitro model to study
signalling pathways by which complement may influence matrix synthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy
-
批准号:8515398
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2011
-
负责人:DAVID J SALANT
-
依托单位:
Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy
-
批准号:8322798
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2011
-
负责人:DAVID J SALANT
-
依托单位:
Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy
-
批准号:8181626
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2011
-
负责人:DAVID J SALANT
-
依托单位:
Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy
-
批准号:8702155
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2011
-
负责人:DAVID J SALANT
-
依托单位:
Podocyte-specific human PLA2R transgenic mouse model of membranous nephropathy
-
批准号:7976290
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2010
-
负责人:DAVID J SALANT
-
依托单位:
Podocyte-specific human PLA2R transgenic mouse model of membranous nephropathy
-
批准号:8103239
-
项目类别:
-
资助金额:$20.91万
-
财政年份:2010
-
负责人:DAVID J SALANT
-
依托单位:
Identification of The Membranous Nephropathy Antigen
-
批准号:6865436
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2004
-
负责人:DAVID J SALANT
-
依托单位:
Identification of The Membranous Nephropathy Antigen
-
批准号:6783756
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2004
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY INDUCED GLOMERULAR INJURY
-
批准号:6478975
-
项目类别:
-
资助金额:$5.36万
-
财政年份:2000
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY INDUCED GLOMERULAR INJURY
-
批准号:6345251
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2000
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY INDUCED GLOMERULAR INJURY
-
批准号:6206446
-
项目类别:
-
资助金额:$0.31万
-
财政年份:1999
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2458841
-
项目类别:
-
资助金额:$28.08万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2749517
-
项目类别:
-
资助金额:$28.97万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2148396
-
项目类别:
-
资助金额:$24.16万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2148397
-
项目类别:
-
资助金额:$24.88万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2148398
-
项目类别:
-
资助金额:$25.45万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY-INDUCED GLOMERULAR INJURY
-
批准号:2138533
-
项目类别:
-
资助金额:$32.73万
-
财政年份:1982
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY-INDUCED GLOMERULAR INJURY
-
批准号:3229740
-
项目类别:
-
资助金额:$20.47万
-
财政年份:1982
-
负责人:DAVID J SALANT
-
依托单位:
Antibody Mediated Glomerular Injury
-
批准号:7188957
-
项目类别:
-
资助金额:$32.05万
-
财政年份:1982
-
负责人:DAVID J SALANT
-
依托单位:
Antibody Mediated Glomerular Injury
-
批准号:7541390
-
项目类别:
-
资助金额:$31.41万
-
财政年份:1982
-
负责人:DAVID J SALANT
-
依托单位:
海外基金